Johnson & Johnson (JNJ) operating KPIs
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)
Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%
Johnson & Johnson oral Care (LISTERINE) — Worldwide currency (FX) impact YoY (%) (%)
Form 8-K EX-99.2 Segment Sales Schedule
Latest, Q2 2023
-1.8%
Period ended Jul 2, 2023
Change on a year earlier
+1.5 pts
-3.3% in Q2 2022
History
23 quarters
Since Q4 2017
Sources
23
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Johnson & Johnson Oral Care (LISTERINE) — Worldwide currency (FX) impact YoY (%) (%), quarterly Q4 2017–Q2 2023 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/ch_oral_care_fx_yoy
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.